Literature DB >> 9338480

Treatment of chlamydial genital infection.

G L Ridgway1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9338480     DOI: 10.1093/jac/40.3.311

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  5 in total

1.  Persistence of Chlamydia trachomatis is induced by ciprofloxacin and ofloxacin in vitro.

Authors:  U Dreses-Werringloer; I Padubrin; B Jürgens-Saathoff; A P Hudson; H Zeidler; L Köhler
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

2.  Identification and characterization of novel recombinant vaccine antigens for immunization against genital Chlamydia trachomatis.

Authors:  Rhea N Coler; Ajay Bhatia; Jean-Francois Maisonneuve; Peter Probst; Brenda Barth; Pamela Ovendale; Hang Fang; Mark Alderson; Yves Lobet; Joe Cohen; Pascal Mettens; Steven G Reed
Journal:  FEMS Immunol Med Microbiol       Date:  2009-03

3.  Sequencing of gyrase and topoisomerase IV quinolone-resistance-determining regions of Chlamydia trachomatis and characterization of quinolone-resistant mutants obtained In vitro.

Authors:  S Dessus-Babus; C M Bébéar; A Charron; C Bébéar; B de Barbeyrac
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

4.  Trachoma decline and widespread use of antimicrobial drugs.

Authors:  Jaya D Chidambaram; Mariko Bird; Vivian Schiedler; Alicia M Fry; Travis Porco; Ramesh C Bhatta; Hem Jha; J S P Chaudary; Bruce Gaynor; Elizabeth Yi; John P Whitcher; Susie Osaki-Holm; Thomas M Lietman
Journal:  Emerg Infect Dis       Date:  2004-11       Impact factor: 6.883

5.  Penicillin kills Chlamydia following the fusion of bacteria with lysosomes and prevents genital inflammatory lesions in C. muridarum-infected mice.

Authors:  Maud Dumoux; Sylvain M Le Gall; Mohamed Habbeddine; Christiane Delarbre; Richard D Hayward; Colette Kanellopoulos-Langevin; Philippe Verbeke
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.